These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21069578)
1. Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center. Szalat A; Fraenkel M; Doviner V; Salmon A; Gross DJ Endocrine; 2011 Apr; 39(2):160-6. PubMed ID: 21069578 [TBL] [Abstract][Full Text] [Related]
2. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. Loh KC; Fitzgerald PA; Matthay KK; Yeo PP; Price DC J Endocrinol Invest; 1997 Dec; 20(11):648-58. PubMed ID: 9492103 [TBL] [Abstract][Full Text] [Related]
3. Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience. Choi YM; Sung TY; Kim WG; Lee JJ; Ryu JS; Kim TY; Kim WB; Hong SJ; Song DE; Shong YK J Surg Oncol; 2015 Dec; 112(8):815-21. PubMed ID: 26464058 [TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute. Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251 [TBL] [Abstract][Full Text] [Related]
5. Pheochromocytoma and paraganglioma in children: a report of 24 cases of the French Society of Pediatric Oncology. Perel Y; Schlumberger M; Marguerite G; Alos N; Revillon Y; Sommelet D; De Lumley L; Flamant F; Dyon JF; Lutz P; Heloury H; Lemerle J Pediatr Hematol Oncol; 1997; 14(5):413-22. PubMed ID: 9267873 [TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892 [TBL] [Abstract][Full Text] [Related]
7. Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. Schlumberger M; Gicquel C; Lumbroso J; Tenenbaum F; Comoy E; Bosq J; Fonseca E; Ghillani PP; Aubert B; Travagli JP J Endocrinol Invest; 1992 Oct; 15(9):631-42. PubMed ID: 1479146 [TBL] [Abstract][Full Text] [Related]
8. [Etiology and clinical guidelines for the diagnosis and treatment of pheochromocytoma in Japan]. Naruse M; Tsuiki M; Nanba K; Nakao K; Tagami T; Tanabe A Nihon Geka Gakkai Zasshi; 2012 Jul; 113(4):378-83. PubMed ID: 22928444 [TBL] [Abstract][Full Text] [Related]
9. High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991. Proye C; Vix M; Goropoulos A; Kerlo P; Lecomte-Houcke M J Endocrinol Invest; 1992 Oct; 15(9):651-63. PubMed ID: 1479148 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of morphology of adrenal pheochromocytoma as regards their potential malignancy]. Kajor M; Ziaja J; Lange D; Król R; Ciupińska-Kajor M; Turska-d'Amico M; Maka B; Cierpka L Endokrynol Pol; 2005; 56(6):911-6. PubMed ID: 16821210 [TBL] [Abstract][Full Text] [Related]
12. The management of benign and malignant pheochromocytoma and abdominal paraganglioma. Edström Elder E; Hjelm Skog AL; Höög A; Hamberger B Eur J Surg Oncol; 2003 Apr; 29(3):278-83. PubMed ID: 12657240 [TBL] [Abstract][Full Text] [Related]
13. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? Agarwal A; Mehrotra PK; Jain M; Gupta SK; Mishra A; Chand G; Agarwal G; Verma AK; Mishra SK; Singh U World J Surg; 2010 Dec; 34(12):3022-8. PubMed ID: 20703467 [TBL] [Abstract][Full Text] [Related]
14. Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years. Hamidi O; Young WF; Iñiguez-Ariza NM; Kittah NE; Gruber L; Bancos C; Tamhane S; Bancos I J Clin Endocrinol Metab; 2017 Sep; 102(9):3296-3305. PubMed ID: 28605453 [TBL] [Abstract][Full Text] [Related]
15. A clinical prediction model to estimate the metastatic potential of pheochromocytoma/paraganglioma: ASES score. Cho YY; Kwak MK; Lee SE; Ahn SH; Kim H; Suh S; Kim BJ; Song KH; Koh JM; Kim JH; Lee SH Surgery; 2018 Sep; 164(3):511-517. PubMed ID: 29929757 [TBL] [Abstract][Full Text] [Related]
16. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma. Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434 [TBL] [Abstract][Full Text] [Related]
17. [Malignant pheochromocytoma responsive to multimodal therapy: a case report]. Mukai M; Kanno N; Nakagawa M; Uemura M; Nishimura K; Miyoshi S; Yoshida K; Kawano K Hinyokika Kiyo; 2003 Oct; 49(10):583-5. PubMed ID: 14655600 [TBL] [Abstract][Full Text] [Related]